Listed

Angiodynamics Inc

ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31

Reports and events: 312 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Angiodynamics Inc, Reports and events
FiledFormWhat it isAccession number
2020-09-0313:51 ETDEF 14AProxy statementPeriod 2020-05-310001275187-20-000028
2020-08-1417:18 ET8-K5.02 Departure or appointment of officers or directors0000914121-20-002881
2020-08-1007:08 ET10-KAnnual reportPeriod 2020-05-310001275187-20-000024
2020-07-1609:58 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-002497
2020-04-0815:56 ET10-QQuarterly reportPeriod 2020-02-290001275187-20-000010
2020-04-0820:27 ET8-K/A2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-001377
2020-04-0707:28 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-001352
2020-02-0708:21 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-20-000537
2020-01-1611:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-000187
2020-01-0814:39 ET10-QQuarterly reportPeriod 2019-11-300001275187-20-000005
2020-01-0707:23 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-000052
2019-11-2018:29 ET8-K5.02 Departure or appointment of officers or directors0000914121-19-003128
2019-10-2216:09 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-19-002807
2019-10-1806:30 ET8-K5.07 Shareholder vote results0000914121-19-002764
2019-10-0415:37 ET10-QQuarterly reportPeriod 2019-08-310001275187-19-000026
2019-10-0306:47 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000914121-19-002640
2019-09-0515:23 ETDEF 14AProxy statementPeriod 2019-05-310001275187-19-000021
2019-08-1616:07 ET8-K5.02 Departure or appointment of officers or directors0000914121-19-002214
2019-07-2510:27 ET10-KAnnual reportPeriod 2019-05-310001275187-19-000017
2019-07-1916:20 ET8-K5.02 Departure or appointment of officers or directors0000914121-19-001929
2019-07-1007:41 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-19-001863
2019-07-1007:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-19-001861
2019-06-0616:37 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000914121-19-001482
2019-06-0616:30 ET8-K5.02 Departure or appointment of officers or directors0000914121-19-001480
2019-04-1808:04 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000914121-19-000934
2019-04-0215:20 ET10-QQuarterly reportPeriod 2019-02-280001275187-19-000014
2019-04-0207:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-19-000777
2019-04-0207:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-19-000775
2019-01-0716:13 ET10-QQuarterly reportPeriod 2018-11-300001275187-19-000009
2019-01-0408:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-19-000012
2019-01-0408:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-19-000011
2018-10-1216:07 ET8-K5.07 Shareholder vote results0000914121-18-001946
2018-10-0116:54 ET10-QQuarterly reportPeriod 2018-08-310001275187-18-000020
2018-09-2707:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-001768
2018-09-2707:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-18-001767
2018-09-0606:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-001672
2018-08-3012:11 ETDEF 14AProxy statementPeriod 2018-05-310001275187-18-000016
2018-07-2317:04 ET10-KAnnual reportPeriod 2018-05-310001275187-18-000011
2018-07-1107:39 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-001308
2018-07-1107:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-18-001307
2018-04-0510:19 ET10-QQuarterly reportPeriod 2018-02-280001275187-18-000007
2018-03-2907:57 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-000576
2018-03-2907:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-18-000574
2018-01-2416:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000914121-18-000124
2018-01-1009:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-000058
2018-01-0515:35 ET10-QQuarterly reportPeriod 2017-11-300001275187-18-000003
2018-01-0407:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-18-000010
2018-01-0407:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-18-000009
2017-10-2016:26 ET8-K5.07 Shareholder vote results0000914121-17-001483
2017-09-2915:18 ET10-QQuarterly reportPeriod 2017-08-310001275187-17-000034

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.